Nutriband’s (NTRB) Board of Directors has approved and declared a 25% preferred stock dividend. Shareholders of record on July 25 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August 5. Each preferred share will be convertible to one share of common stock following FDA approval of the Company’s AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual basis as decided by the board of Directors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRB: